Endothelial‐to‐mesenchymal transition in the fetoplacental macrovasculature and microvasculature in pregnancies complicated by gestational diabetes
Endothelial-zu-mesenchymale Transition in der fetoplazentaren Makro- und Mikrovasculatur bei Schwangerschaften mit Gestationsdiabetes
The Journal of Physiology · 2026-06 · 604 (11) · 4405-4425
DOI: 10.1113/jp287931 ↗Auf einen Blick
Untersucht wurde, ob Veränderungen der fetoplazentaren Gefäße bei Gestationsdiabetes mit EndMT zusammenhängen. TGF-β2 und IL-1β lösten EndMT-ähnliche Veränderungen aus; dies erklärt die Gefäßstörung aber wohl nicht vollständig.
Fragestellung
Sind Veränderungen der fetoplazentaren Makro- und Mikrovasculatur bei Gestationsdiabetes auf eine endotheliale-zu-mesenchymale Transition zurückzuführen?
Methode
Untersuchung an humanen HUVECs und humanem Placentagewebe am Termin; Vergleich von GDM- und Nicht-GDM-Proben nach Stimulation mit TGF-β2 und IL-1β.
Ergebnisse
TGF-β2 und IL-1β führten in GDM- und Nicht-GDM-HUVECs zu morphologischen und molekularen EndMT-Veränderungen. In GDM-Plazenten waren PECAM1, VWF und CDH5 vermindert; auch SNAI2, TGB2, TGFB3 und TGFBR2 nahmen ab.
Einschränkungen
Keine.
Schlussfolgerung der Autor:innen
Es gibt möglicherweise Veränderungen der EndMT bei GDM, diese erklären die endotheliale Dysfunktion und veränderte Vaskularisierung in der fetoplazentaren Vasculatur aber wahrscheinlich nicht vollständig.
Kernaussagen
- TGF-β2 und IL-1β induzierten EndMT-ähnliche Veränderungen in HUVECs
- GDM-Plazenten zeigten reduzierte endotheliale Marker
- Die vaskuläre Dysfunktion ist wohl nicht allein durch EndMT erklärbar
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physiology, online erschienen am 11.05.2025. Verfasst von Abigail R Byford und 9 weiteren Autor:innen. Beteiligte Einrichtung: Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University …. Hauptthemen laut MEDLINE: Diabetes, Gestational, Endothelial-Mesenchymal Transition, Placenta, Microvessels. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UKRI | Medical Research Council (MRC), University of Leeds, King Saud bin Abdulaziz University for Health Sciences.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Gestational diabetes mellitus (GDM) is linked to altered fetal development and an increased risk of offspring developing cardiometabolic diseases in adulthood. The mechanisms responsible are unclear; however, GDM is associated with altered fetoplacental vascularisation, fibrosis and endothelial dysfunction. In non‐pregnant individuals with diabetes, similar vascular changes are attributed to disruptions in endothelial‐to‐mesenchymal transition (EndMT), a key process where endothelial cells adopt a mesenchymal phenotype. Here, we assess whether alterations in the fetoplacental macro‐ and microvasculature are attributed to EndMT, using human umbilical vein endothelial cells (HUVECs) and human term placental tissue, respectively. Transforming growth factor (TGF)‐β2 and interleukin (IL)‐1β induced morphological and molecular changes consistent with EndMT in both GDM and non‐GDM HUVECs. The ability of TGF‐β2 and IL‐1β to alter expression of known EndMT regulators, VWF , TGFBR1 , IL1B and IL1R1 , was diminished in GDM HUVECs; however, all other hallmarks of EndMT were similar. In placental villous tissue, Slug and Snail, two key transcriptional regulators of EndMT, were detected in the villous stroma, suggesting that EndMT probably occurs in the placental microvasculature. We observed a reduction in endothelial marker genes PECAM1 , VWF and CDH5 in GDM placentas, suggesting reduced placental vascularisation. This was accompanied by a reduction in EndMT regulators SNAI2 , TGB2 , TGFB3 and TGFBR2 ; however, there was no change in mesenchymal markers or other EndMT regulators. This suggests that there may be some alterations in EndMT in GDM but this probably does not fully explain the endothelial dysfunction and altered vascularisation that occurs in the fetoplacental vasculature in pregnancies complicated by GDM. image Key points Gestational diabetes mellitus (GDM) has been linked to altered placental vascularisation, fibrosis and endothelial dysfunction. Disruptions in endothelial‐to‐mesenchymal transition (EndMT), a process where endothelial cells adopt a mesenchymal phenotype, has been linked to vascular complications in diabetes, but EndMT in GDM has not been investigated. Transforming growth factor (TGF)‐β2 and interleukin (IL)‐1β induced morphological and molecular changes consistent with EndMT in GDM and non‐GDM human umbilical vein endothelial cells (HUVECs). Although the expression of EndMT mediators, VWF , TGFBR1 , IL1B , and IL1R1 , was diminished in GDM HUVECs, other EndMT hallmarks were similar. Transcriptional regulators of EndMT, Slug and Snail, were detected in the human term placenta. Despite a reduction in endothelial markers, PECAM1 , VWF and CDH5 , as well as SNAI2 , TGFB2/3 and TGFBR2 in GDM placenta, there was no change in mesenchymal or other EndMT markers. This suggests that, although there may be some changes to EndMT in GDM, the vascular dysfunction is probably not explained fully by alterations in EndMT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
- Institute of Reproductive and Developmental Biology (IRDB), Imperial College London, London, UK.
- Clinical and Population Sciences, Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
ORCID-Profile: Abigail R Byford, Georgia Fakonti, Sharanam Soni, Sophie L Earle, Lara C Morley, Beth Holder, Eleanor M Scott, Karen Forbes
Förderung
- UKRI | Medical Research Council (MRC)
- University of Leeds
- King Saud bin Abdulaziz University for Health Sciences
- National Institute for Health and Care Research (NIHR)
Zitieren
APA
Byford, A. R., Fakonti, G., Shao, Z., Soni, S., Earle, S. L., Bajarwan, M., Morley, L. C., Holder, B., Scott, E. M., & Forbes, K. (2026). Endothelial‐to‐mesenchymal transition in the fetoplacental macrovasculature and microvasculature in pregnancies complicated by gestational diabetes. The Journal of Physiology, 604(11), 4405-4425. https://doi.org/10.1113/jp287931
Vancouver
Byford AR, Fakonti G, Shao Z, Soni S, Earle SL, Bajarwan M, et al. Endothelial‐to‐mesenchymal transition in the fetoplacental macrovasculature and microvasculature in pregnancies complicated by gestational diabetes. The Journal of Physiology. 2026;604(11):4405-4425. doi:10.1113/jp287931
BibTeX
@article{Byford2026,
author = {Byford, Abigail R and Fakonti, Georgia and Shao, Ziyu and Soni, Sharanam and Earle, Sophie L and Bajarwan, Muath and Morley, Lara C and Holder, Beth and Scott, Eleanor M and Forbes, Karen},
title = {Endothelial‐to‐mesenchymal transition in the fetoplacental macrovasculature and microvasculature in pregnancies complicated by gestational diabetes},
journal = {The Journal of Physiology},
year = {2026},
volume = {604},
number = {11},
pages = {4405--4425},
doi = {10.1113/jp287931}
}
EUVIMED